Ketogenic dietary therapy for epilepsy and other disorders: current perspectives

References

• Guelpa G, Marie A. La lutte contre l’epilepsie par la desintoxication et par la reeducation alimentaire. Revue de Therapie Medico-Chirurgicale. 1911;78:8–13.
   Google Scholar
• Geyelin HR. Fasting as a method for treating epilepsy. Medical Recordings. 1921;99:1037–1039.
   Google Scholar
• Wilder RM. The effect of ketonemia on the course of epilepsy. Mayo Clinic Bulletin. 1921;2:307.
   Google Scholar
• Peterman MG. The ketogenic diet in the treatment of epilepsy: a preliminary report. Archives of Pediatrics and Adolescent Medicine. 1924;28(1):28–33.
   Google Scholar
• Helmholz HF. The treatment of epilepsy in childhood: five years’ experience with the ketogenic diet. JAMA. 1927;88(26):2028–2032.
   Google Scholar
• Talbot FB, Metcalf KM, Moriarty ME. A clinical study of epileptic children treated by the ketogenic diet. The Boston Medical and Surgical Journal. 1927;196(3):89–96.
   Google Scholar
• McQuarrie I, Keith HM. Epilepsy in children: relationship of variations in the degree of ketonuria to occurrence of convulsions in epileptic children on ketogenic diets. Archives of Pediatrics and Adolescent Medicine. 1927;34:1013–1029.
   Google Scholar
• Lennox WG. Ketogenic diet in the treatment of epilepsy. N Engl J Med. 1928;199(2):74–75.
   Google Scholar
• Barborka CJ. Epilepsy in adults: results of treatment by ketogenic diet in one hundred cases. Archives of Neurology and Psychiatry. 1930;23(5):904–914.
   Google Scholar
• Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 1971;21(11):1097–1103.
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003;61(12):1789–1791.
   PubMed Web of Science ®Google Scholar
• Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 2005;65(11):1810–1812.
   PubMed Web of Science ®Google Scholar
• Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics. 2000;105(4):E46.
   PubMed Web of Science ®Google Scholar
• Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol. 2006;35(1):1–5.
   PubMed Web of Science ®Google Scholar
• Henderson CB, Filloux FM, Alder SC, Lyon JL, Caplin DA. Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol. 2006;21(3):193–198.
   Web of Science ®Google Scholar
• Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet in the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7(6):500–506.
   PubMed Web of Science ®Google Scholar
• Neal EG, Chaffe H, Schwartz RH, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009;50(5):1109–1117.
   PubMed Web of Science ®Google Scholar
• Auvin S. Should we routinely use modified Atkins diet instead of regular ketogenic diet to treat children with epilepsy? Seizure. 2012;21(4):237–240.
   PubMed Web of Science ®Google Scholar
• Muzykewicz DA, Lyczkowski DA, Memon N, Conant KD, Pfeifer HH, Thiele EA. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia. 2009;50(5):1118–1126.
   PubMed Web of Science ®Google Scholar
• Levy RG, Cooper PN, Giri P. Ketogenic diet and other dietary treatments for epilepsy [review]. Cochrane Database Syst Rev. 2012;3:CD001903.
   Google Scholar
• Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia. 2013;54(3):481–486.
   PubMed Web of Science ®Google Scholar
• El-Rashidy OF, Nassar MF, Abdel-Hamid IA, et al. Modified Atkins diet vs classic ketogenic formula in intractable epilepsy. Acta Neurol Scand. 2013;128(6):402–408.
   PubMed Web of Science ®Google Scholar
• Nangia S, Caraballo RH, Kang HC, Nordli DR, Scheffer IE. Is the ketogenic diet effective in specific epilepsy syndromes? Epilepsy Res. 2012;100(3):252–257.
   Web of Science ®Google Scholar
• Kossoff EH, Zupec-Kania BA, Amark PE, et al. Charlie Foundation, Practice Committee of the Child Neurology Society; Practice Committee of the Child Neurology Society; International Ketogenic Diet Study Group. Optimal clinical management of children receiving the ketogenic diet: recommendations of the international ketogenic diet study group. Epilepsia. 2009;50(2):304–317.
   PubMed Web of Science ®Google Scholar
• Payne NE, Cross JH, Sander JW, Sisodiya SM. The ketogenic and related diets in adolescents and adults – a review. Epilepsia. 2011;52(11):1941–1948.
   PubMed Web of Science ®Google Scholar
• Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007;48(1):43–58.
   PubMed Web of Science ®Google Scholar
• Hartman AL, Rho JM. . The biochemical basis of dietary therapies for neurological disorders. In: Neal EG, editor. Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. Oxford, UK: Wiley-Blackwell; 2012:34–44.
   Google Scholar
• Lutas A, Yellen G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 2013;36(1):32–40.
   PubMed Web of Science ®Google Scholar
• Danial NN, Hartman AL, Stafstrom CE, Thio LL. How does the ketogenic diet work? Four potential mechanisms. J Child Neurol. 2013;28(8):1027–1033.
   PubMed Web of Science ®Google Scholar
• Chang P, Terbach N, Plant N, Chen PE, Walker MC, Williams RS. Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology. 2013;69:105–114.
   PubMed Web of Science ®Google Scholar
• Bergqvist AG, Schall JI, Gallagher PR, Cnaan A, Stallings VA. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia. 2005;46(11):1810–1819.
   PubMed Web of Science ®Google Scholar
• Vaisleib II, Buchhalter JR, Zupanc ML. Ketogenic diet: outpatient initiation, without fluid, or caloric restrictions. Pediatr Neurol. 2004;31(3):198–202.
   Web of Science ®Google Scholar
• Rizzutti S, Ramos AM, Muszkat M, Gabbai AA. Is hospitalization really necessary during the introduction of the ketogenic diet? J Child Neurol. 2007;22(2):33–37.
   Google Scholar
• Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004;45(9):1116–1123.
   PubMed Web of Science ®Google Scholar
• Kwiterovich PO Jr, Vining EP, Pyzik P, Skolasky R Jr, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA. 2003;290(7):912–919.
   PubMed Web of Science ®Google Scholar
• Vining EPG, Pyzik P, McGrogan J, et al. Growth of children on the ketogenic diet. Dev Med Child Neurol. 2002;44(12):796–802.
   Web of Science ®Google Scholar
• Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol. 2007;22(4):375–378.
   PubMed Web of Science ®Google Scholar
• Bergqvist AG, Schall JI, Stallings VA. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia. 2007;48(1):66–71.
   PubMed Web of Science ®Google Scholar
• Bergqvist AG, Schall JI, Stallings VA, Zemel BS. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr. 2008;88(6):1678–1684.
   PubMed Web of Science ®Google Scholar
• Bergqvist AG, Chee CM, Lutchka L, Rychik J, Stallings VA. Selenium deficiency associated with cardiomyopathy: a complication of the ketogenic diet. Epilepsia. 2003;44(4):618–620.
   Web of Science ®Google Scholar
• Bank IM, Shemie SD, Rosenblatt B, Bernard C, Mackie AS. Sudden cardiac death in association with the ketogenic diet. Pediatr Neurol. 2008;39(6):429–431.
   Web of Science ®Google Scholar
• Christodoulides SS, Neal EG, Fitzsimmons G, et al. The effect of the classical and medium chain triglyceride ketogenic diet on vitamin and mineral levels. J Hum Nutr Diet. 2012;25(1):16–26.
   Web of Science ®Google Scholar
• Willmott NS, Bryan RA. Case report: scurvy in an epileptic child on a ketogenic diet with oral complications. Eur Arch Paediatr Dent. 2008;9(3):148–152.
   Google Scholar
• Anil M, Helvaci M, Ozbal E, Kalenderer O, Anil AB, Dilek M. Serum and muscle carnitine levels in children receiving sodium valproate. J Child Neurol. 2009;24(1):80–86.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Abdella MM. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. Epilepsy Res. 2009;86(1):32–41.
   PubMed Web of Science ®Google Scholar
• Berry-Kravis E, Booth G, Sanchez AC, Woodbury-Kolb J. Carnitine levels and the ketogenic diet. Epilepsia. 2001;42(11):1445–1451.
   Web of Science ®Google Scholar
• Dahlin M, Hjelte L, Nilsson S, Amark P. Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res. 2007;73(2):199–207.
   PubMed Web of Science ®Google Scholar
• Liu YM, Lowe H, Zak MM, Kobayashi J, Chan VW, Donner EJ. Can children with hyperlipidemia receive ketogenic diet for medication-resistant epilepsy? J Child Neurol. 2013;28(4):479–483.
   Web of Science ®Google Scholar
• Leen WG, Klepper J, Verbeek MM, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain. 2010;133(Pt 3):655–670.
   Google Scholar
• Klepper J. Impaired glucose transport into the brain: the expanding spectrum of glucose transporter type 1 deficiency syndrome. Curr Opin Neurol. 2004;17(2):193–196.
   Web of Science ®Google Scholar
• Klepper J, Scheffer H, Leiendecker B, et al. Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively. Neuropediatrics. 2005;36(5):302–308.
   Web of Science ®Google Scholar
• Klepper J, Diefenbach S, Kohlschütter A, Voit T. Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. Prostaglandins Leukot Essent Fatty Acids. 2004;70(3):321–327.
   Web of Science ®Google Scholar
• Brockmann K. The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev. 2009;31(7):545–552.
   Web of Science ®Google Scholar
• Ito S, Oguni H, Ito Y, Ishigaki K, Ohinata J, Osawa M. Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome. Brain Dev. 2008;30(3):226–228.
   Web of Science ®Google Scholar
• Slaughter L, Vartzelis G, Arthur T. New GLUT-1 mutation in a child with treatment-resistant epilepsy. Epilepsy Res. 2009;84(2–3):254–256.
   Web of Science ®Google Scholar
• Prasad C, Rupar T, Prasad AN. Pyruvate dehydrogenase deficiency and epilepsy. Brain Dev. 2011;33(10):856–865.
   Web of Science ®Google Scholar
• Wexler ID, Hemalatha SG, McConnell J, et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology. 1997;49(6):1655–1661.
   Web of Science ®Google Scholar
• El-Gharbawy AH, Boney A, Young SP, Kishnani PS. Follow-up of a child with pyruvate dehydrogenase deficiency on a less restrictive ketogenic diet. Mol Genet Metab. 2011;102(2):214–215.
   Web of Science ®Google Scholar
• Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol. 2012;3:59.
   PubMed Web of Science ®Google Scholar
• Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67(8):789–796.
   PubMed Web of Science ®Google Scholar
• Warburg O, Posener K, Negelein E. Über den Stoffwechsel der Carcinomzelle. Biochem Zeitschr. 1924:309–344.
   Google Scholar
• Klement RJ, Kämmerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond). 2011; 8:75.
   PubMed Web of Science ®Google Scholar
• Seyfried TN, Mukherjee P. Targeting energy metabolism in brain cancer: review and hypothesis. Nutr Metab (Lond). 2005;2:30.
   Google Scholar
• Tisdale MJ, Brennan RA, Fearon KC. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer. 1987;56(1):39–43.
   Web of Science ®Google Scholar
• Tisdale MJ, Brennan RA. A comparison of long-chain triglycerides and medium-chain triglycerides on weight loss and tumour size in a cachexia model. Br J Cancer. 1988;58(5):580–583.
   Web of Science ®Google Scholar
• Freedland SJ, Mavropoulos J, Wang A, et al. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate. 2008;68(1):11–19.
   PubMed Web of Science ®Google Scholar
• Otto C, Kaemmerer U, Illert B, et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer. 2008;8:122.
   PubMed Web of Science ®Google Scholar
• Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond). 2007;4:5.
   PubMed Web of Science ®Google Scholar
• Stafford P, Abdelwahab MG, Kim do Y, Preul MC, Rho JM, Scheck AC. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond). 2010;7:74.
   PubMed Web of Science ®Google Scholar
• Nebeling LC, Miraldi F, Shurin SB, Lerner E. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr. 1995;14(2):202–208.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pfetzer N, Schwab M, Strauss I, Kämmerer U. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutr Metab (Lond). 2011;8(1):54.
   PubMedGoogle Scholar
• Barañano KW, Hartman AL. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr Treat Options Neurol. 2008;10(6):410–419.
   Google Scholar
• Tieu K, Perier C, Caspersen C, et al. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest. 2003;112(6):892–901.
   PubMed Web of Science ®Google Scholar
• Vanitallie TB, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology. 2005;64(4):728–730.
   PubMed Web of Science ®Google Scholar
• Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009;6:31.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Lange DJ, Voustianiouk A, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29.
   PubMed Web of Science ®Google Scholar